- Home
- ATRA vs ANEB Comparison
ATRA vs ANEB Comparison
Compare ATRA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- ANEB
- Stock Information
- Founded
- ATRA 2012
- ANEB 2020
- Country
- ATRA United States
- ANEB United States
- Employees
- ATRA N/A
- ANEB N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- ANEB Health Care
- Exchange
- ATRA Nasdaq
- ANEB Nasdaq
- Market Cap
- ATRA 39.7M
- ANEB 36.7M
- IPO Year
- ATRA 2014
- ANEB 2021
- Fundamental
- Price
- ATRA $6.86
- ANEB $1.43
- Analyst Decision
- ATRA Buy
- ANEB Buy
- Analyst Count
- ATRA 6
- ANEB 1
- Target Price
- ATRA $25.70
- ANEB $8.00
- AVG Volume (30 Days)
- ATRA 71.1K
- ANEB 25.7K
- Earning Date
- ATRA 03-07-2025
- ANEB 02-14-2025
- Dividend Yield
- ATRA N/A
- ANEB N/A
- EPS Growth
- ATRA N/A
- ANEB N/A
- EPS
- ATRA N/A
- ANEB N/A
- Revenue
- ATRA $128,940,000.00
- ANEB N/A
- Revenue This Year
- ATRA N/A
- ANEB N/A
- Revenue Next Year
- ATRA N/A
- ANEB N/A
- P/E Ratio
- ATRA N/A
- ANEB N/A
- Revenue Growth
- ATRA 1404.02
- ANEB N/A
- 52 Week Low
- ATRA $5.40
- ANEB $0.80
- 52 Week High
- ATRA $20.83
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- ATRA 41.62
- ANEB 58.07
- Support Level
- ATRA $5.94
- ANEB $0.91
- Resistance Level
- ATRA $7.02
- ANEB $1.70
- Average True Range (ATR)
- ATRA 0.58
- ANEB 0.19
- MACD
- ATRA 0.07
- ANEB 0.04
- Stochastic Oscillator
- ATRA 52.36
- ANEB 65.91
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.